DNA-PKcs Inhibition Improves Sequential Gene Insertion of the Full-length CDNA in Airway Stem Cells

Overview

Journal Mol Ther Nucleic Acids

Publisher Cell Press

Date 2024 Oct 14

PMID 39398224

Authors

Jacob T Stack

Rachael E Rayner

Reza Nouri

Carlos J Suarez

Sun Hee Kim

Karen L Kanke

Tatyana A Vetter

Estelle Cormet-Boyaka

Sriram Vaidyanathan

Affiliations

Soon will be listed here.

Abstract

Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator () gene. Although many people with CF (pwCF) are treated using CFTR modulators, some are non-responsive due to their genotype or other uncharacterized reasons. Autologous airway stem cell therapies, in which the cDNA has been replaced, may enable a durable therapy for all pwCF. Previously, CRISPR-Cas9 with two AAVs was used to sequentially insert two-halves of the cDNA and an enrichment cassette into the locus. However, the editing efficiency was <10% and required enrichment to restore CFTR function. Further improvement in gene insertion may enhance cell therapy production. To improve cDNA insertion in human airway basal stem cells (ABCs), we evaluated the use of the small molecules AZD7648 and ART558, which inhibit non-homologous end-joining (NHEJ) and micro-homology mediated end-joining (MMEJ). Adding AZD7648 alone improved gene insertion by 2- to 3-fold. Adding both ART558 and AZD7648 improved gene insertion but induced toxicity. ABCs edited in the presence of AZD7648 produced differentiated airway epithelial sheets with restored CFTR function after enrichment. Adding AZD7648 did not increase off-target editing. Further studies are necessary to validate if AZD7648 treatment enriches cells with oncogenic mutations.

References

Ning K, Zhang X, Feng Z, Hao S, Kuz C, Cheng F . Inhibition of DNA-dependent protein kinase catalytic subunit boosts rAAV transduction of polarized human airway epithelium. Mol Ther Methods Clin Dev. 2023; 31:101115. PMC: 10568418. DOI: 10.1016/j.omtm.2023.101115. View

Hawkins F, Suzuki S, Beermann M, Barilla C, Wang R, Villacorta-Martin C . Derivation of Airway Basal Stem Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2020; 28(1):79-95.e8. PMC: 7796997. DOI: 10.1016/j.stem.2020.09.017. View

Hayes Jr D, Kopp B, Hill C, Lallier S, Schwartz C, Tadesse M . Cell Therapy for Cystic Fibrosis Lung Disease: Regenerative Basal Cell Amplification. Stem Cells Transl Med. 2018; 8(3):225-235. PMC: 6392379. DOI: 10.1002/sctm.18-0098. View

Robinson E, MacDonald K, Slaughter K, McKinney M, Patel S, Sun C . Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis. Mol Ther. 2018; 26(8):2034-2046. PMC: 6094356. DOI: 10.1016/j.ymthe.2018.05.014. View

Plasschaert L, Zilionis R, Choo-Wing R, Savova V, Knehr J, Roma G . A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte. Nature. 2018; 560(7718):377-381. PMC: 6108322. DOI: 10.1038/s41586-018-0394-6. View

Schimmel J, Munoz-Subirana N, Kool H, van Schendel R, van der Vlies S, Kamp J . Modulating mutational outcomes and improving precise gene editing at CRISPR-Cas9-induced breaks by chemical inhibition of end-joining pathways. Cell Rep. 2023; 42(2):112019. DOI: 10.1016/j.celrep.2023.112019. View

Selvaraj S, Feist W, Viel S, Vaidyanathan S, Dudek A, Gastou M . High-efficiency transgene integration by homology-directed repair in human primary cells using DNA-PKcs inhibition. Nat Biotechnol. 2023; 42(5):731-744. DOI: 10.1038/s41587-023-01888-4. View

Cromer M, Barsan V, Jaeger E, Wang M, Hampton J, Chen F . Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells. Nat Commun. 2022; 13(1):4724. PMC: 9372057. DOI: 10.1038/s41467-022-32233-z. View

Suzuki S, Crane A, Anirudhan V, Barilla C, Matthias N, Randell S . Highly Efficient Gene Editing of Cystic Fibrosis Patient-Derived Airway Basal Cells Results in Functional CFTR Correction. Mol Ther. 2020; 28(7):1684-1695. PMC: 7335734. DOI: 10.1016/j.ymthe.2020.04.021. View

10.

Wagner J, Nepomuceno I, Messner A, Moran M, Batson E, DiMiceli S . A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum Gene Ther. 2002; 13(11):1349-59. DOI: 10.1089/104303402760128577. View

11.

Butler C, Hynds R, Gowers K, Lee D, Brown J, Crowley C . Rapid Expansion of Human Epithelial Stem Cells Suitable for Airway Tissue Engineering. Am J Respir Crit Care Med. 2016; 194(2):156-68. PMC: 5003214. DOI: 10.1164/rccm.201507-1414OC. View

12.

Keating D, Marigowda G, Burr L, Daines C, Mall M, McKone E . VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N Engl J Med. 2018; 379(17):1612-1620. PMC: 6289290. DOI: 10.1056/NEJMoa1807120. View

13.

Cradick T, Fine E, Antico C, Bao G . CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res. 2013; 41(20):9584-92. PMC: 3814385. DOI: 10.1093/nar/gkt714. View

14.

Cooney A, Abou Alaiwa M, Shah V, Bouzek D, Stroik M, Powers L . Lentiviral-mediated phenotypic correction of cystic fibrosis pigs. JCI Insight. 2016; 1(14). PMC: 5027966. DOI: 10.1172/jci.insight.88730. View

15.

Tiroille V, Krug A, Bokobza E, Kahi M, Bulcaen M, Ensinck M . Nanoblades allow high-level genome editing in murine and human organoids. Mol Ther Nucleic Acids. 2023; 33:57-74. PMC: 10331042. DOI: 10.1016/j.omtn.2023.06.004. View

16.

Excoffon K, Koerber J, Dickey D, Murtha M, Keshavjee S, Kaspar B . Directed evolution of adeno-associated virus to an infectious respiratory virus. Proc Natl Acad Sci U S A. 2009; 106(10):3865-70. PMC: 2646629. DOI: 10.1073/pnas.0813365106. View

17.

Lieu N, Prentice B, Field P, Fitzgerald D . Trials and tribulations of highly effective modulator therapies in cystic fibrosis. Paediatr Respir Rev. 2023; 48:10-19. DOI: 10.1016/j.prrv.2023.09.001. View

18.

Ihry R, Worringer K, Salick M, Frias E, Ho D, Theriault K . p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med. 2018; 24(7):939-946. DOI: 10.1038/s41591-018-0050-6. View

19.

Bak R, Porteus M . CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors. Cell Rep. 2017; 20(3):750-756. PMC: 5568673. DOI: 10.1016/j.celrep.2017.06.064. View

20.

Ghosh M, Ahmad S, White C, Reynolds S . Transplantation of Airway Epithelial Stem/Progenitor Cells: A Future for Cell-Based Therapy. Am J Respir Cell Mol Biol. 2016; 56(1):1-10. PMC: 5248965. DOI: 10.1165/rcmb.2016-0181MA. View